Two expressions of concern arrive for papers linked to beleaguered biotech Cassava
The Journal of Neuroscience has slapped expressions of concern on a pair of papers linked to the maker of a controversial drug to treat Alzheimer’s disease. As we and others have reported, Cassava Sciences has been under intense scrutiny lately. In August, the law firm Labaton Sucharow – who is representing Cassava short sellers – … Continue reading Two expressions of concern arrive for papers linked to beleaguered biotech Cassava